Table 1 Subjects characteristics
Characteristics | Test set 1 | Test set 2 | Pilot set | ||||||
|---|---|---|---|---|---|---|---|---|---|
ITP (n = 201) | Non-ITP (n = 126) | HC (n = 207) | ITP (n = 41) | Non-ITP (n = 37) | HC (n = 36) | ITP (n = 8) | |||
Disease subtype (n) | Newly-diagnosed (63) | Persistent (60) | Chronic (78) | NA | NA | NA | NA | NA | Newly-diagnosed (8) |
Gender (female/male, n) | 45/18 | 38/22 | 48/30 | 56/70 | 76/131 | 24/17 | 11/26 | 13/23 | 5/3 |
Age (median, range, years) | 53 (18, 86) | 53 (9, 86) | 54 (13, 83) | 44 (13, 88) | 48 (24, 91) | 33 (5, 68) | 42 (9, 64) | 30 (21, 50) | 38.5 (9, 69) |
Platelet count (× 109/L)a | 29.0 ± 16.9 | 41.0 ± 20.0 | 42.4 ± 20.3 | 41.5 ± 21.8 | 216.1 ± 56.8 | 38.2 ± 32.3 | 42.2 ± 31.0 | 211.4 ± 32.4 | 17.8 ± 9.9 |
Treatment (n, %)b | NA | 58 (96.7) | 78 (100) | NA | NA | 27 (65.9) | NA | NA | NA |
Steroids | NA | 51 (85.0) | 75 (96.2) | NA | NA | 27 (65.9) | NA | NA | NA |
Immunosuppressants | NA | 15 (25.0) | 27 (34.6) | NA | NA | 10 (24.4) | NA | NA | NA |
Splenectomy | NA | 0 (0) | 3 (3.8) | NA | NA | 0 (0) | NA | NA | NA |
Others | NA | 10 (16.7) | 23 (29.5) | NA | NA | 5 (12.2) | NA | NA | NA |